Activity of c-Met/ALK inhibitor crizotinib and multi-kinase VEGF inhibitor pazopanib in metastatic gastrointestinal neuroectodermal tumor harboring EWSR1-CREB1 fusion

Vivek Subbiah, Oliver Holmes, Kyle Gowen, Daniel Spritz, Behrang Amini, Wei Lien Wang, Alexa B. Schrock, Funda Meric-Bernstam, Ralph G Zinner, Sarina Piha-Paul, Maria Zarzour, Julia A. Elvin, Rachel L. Erlich, David L. Stockman, Jo Anne Vergilio, James H. Suh, Philip J. Stephens, Vincent Miller, Jeffrey S. Ross, Siraj M. Ali

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Activity of c-Met/ALK inhibitor crizotinib and multi-kinase VEGF inhibitor pazopanib in metastatic gastrointestinal neuroectodermal tumor harboring EWSR1-CREB1 fusion'. Together they form a unique fingerprint.

Medicine & Life Sciences